期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
On the Gender Difference of Translator's Subjectivity in Literary Translation
1
作者 陈志海 董淑新 王齐 《海外英语》 2014年第22期120-122,125,共4页
Translation is an activity aimed at transferring the source language to the target language,related to many aspects involving culture,society,history and so on.The translator plays a critical role in translation pract... Translation is an activity aimed at transferring the source language to the target language,related to many aspects involving culture,society,history and so on.The translator plays a critical role in translation practice.Xu Jun considers"translator’s subjectivity should be reflected to be artistic personal consciousness in translated works."Translator’s differences in age,gender,personal traits,educational level and other aspects make translation artistry completely divergent.Therefore,translator’s subjectivity shoulders great significances on the success of literary translation,which isn’t arbitrary,out of control,must be conducted in line with essence of the original work.This paper focuses on the gender difference of translator’s subjectivity in literary translation,hoping to find a way of eliminating the influence of it in the translation work. 展开更多
关键词 translator’s SUBJECTIVITY GENDER DIFFERENCE androg
下载PDF
激素难治性前列腺癌组织中雄激素受体蛋白表达的研究 被引量:6
2
作者 张勇 陈炜 +1 位作者 胡笑克 桂治宁 《癌症》 SCIE CAS CSCD 北大核心 2003年第1期95-97,共3页
背景与目的:近来有研究报道,在激素难治性前列腺癌(hormonerefractoryprostatecarcinoma,HRPC)中发现有雄激素受体(androgenreceptor,AR)基因扩增,并提出AR基因扩增可能是导致激素治疗失败的一个新的分子机制。本研究拟对前列腺癌在激... 背景与目的:近来有研究报道,在激素难治性前列腺癌(hormonerefractoryprostatecarcinoma,HRPC)中发现有雄激素受体(androgenreceptor,AR)基因扩增,并提出AR基因扩增可能是导致激素治疗失败的一个新的分子机制。本研究拟对前列腺癌在激素治疗前和治疗失败后的AR蛋白表达作定量测定,进一步探讨AR表达与HRPC发生的关系。方法:采用放射配体结合分析方法测定28例晚期前列腺癌患者在激素治疗前以及治疗失败后原发癌组织中的AR蛋白含量。结果:28例前列腺癌在治疗前、后癌组织中的AR蛋白平均水平分别为(390.0±204.1)和(690.4±444.0)fmol/mgProtein,两者间差异有显著性(P<0.001)。其中10例在治疗后12个月内复发,其AR蛋白平均水平在治疗前、后分别为(398.2±199.5)和(448.2±274.1)fmol/mgProtein两者间差异无显著性(P>0.20),其余18例的AR蛋白平均水平在治疗前、后分别为(386.4±212.3)和(824.9±468.6)fmol/mgProtein,两者间差异有显著性(P<0.001)。结论:AR蛋白水平升高可能是前列腺癌对激素治疗不敏感的原因之一。 展开更多
关键词 前列腺肿瘤 雄激素受体 抗雄激素治疗 蛋白表达 放射配体结合分析法
下载PDF
天然产物新靶点:自噬-溶酶体途径(英文)
3
作者 沈汉明 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2015年第S1期7-7,共1页
Autophagy is an evolutionarily well conserved process in which the cellular components including damaged subcellular organelles are engulfed in autophagosome and eventually delivered to lysosome for degradation.It has... Autophagy is an evolutionarily well conserved process in which the cellular components including damaged subcellular organelles are engulfed in autophagosome and eventually delivered to lysosome for degradation.It has been well studied that autophagy is closely implicated in many diseases such as cancer and neurodegenerative diseases.Therefore,the autophagy-lysosome pathway becomes an attractive target in developing novel therapeutic approaches.In the past several years,we have studied the effects of several natural products on the autophagy-lysosome pathway:(i)Andrographolide(Andro),a diterpenoid lactone isolated from an herbal plant Andrographispaniculata,is capable of suppressing autophagy and sensitizing cisplatin-mediated apoptosis in human cancer cells,via blockage of autophagosome-lysosome fusion;(ii)(-)-Epigallocatechin-3-gallate(EGCG),an important green tea polyphenol,induces lysosomal membrane permeabilization(LMP)and eventually leads to lysosome-associated cell death;and(iii)Artesunate(ART),an analog of artemisinin,an anti-malaria drug,is able to kill cancer cells via enhancing lysosomal function and induction of lysosomal degradation of ferritin.Collectively,our findings reveal novel insights into the molecular mechanisms underlying the anti-cancer properties of those natural compounds and demonstrate that targeting the autophagy-lysosome pathway could serve as a new strategy in developing anti-cancer therapeutic agents. 展开更多
关键词 autophagy-lysosome PATHWAY NATURAL PRODUCTS androg
下载PDF
整合化学和定量蛋白质组学方法用于鉴定药物靶点(英文)
4
作者 林青松 王继刚 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2015年第S1期21-21,共1页
Most drugs exert pharmacological effects through interaction with their target proteins.Therefore,drug target identification is a crucial step towards the understanding of the mechanism of drug action.It is also imper... Most drugs exert pharmacological effects through interaction with their target proteins.Therefore,drug target identification is a crucial step towards the understanding of the mechanism of drug action.It is also imperative to study the pharmacodynamics of a known drug,with an aim to discover the potentially unrevealed actions and thus refine its future clinical applications.Currently,drug-target identification is either through in vitro affinity chromatography-based approaches or in vivo activity-based protein profiling(ABPP)approaches.However,these approaches generally face difficulties discriminating specific drug targets from non-specific ones.To address this issue,we have come up with a strategy by coupling iTRAQTM(isobaric tags for relative and absolute quantitation)quantitative proteomics approach with clickable ABPP,to specifically and compre hensively identify drug targets in live cells.Using this approach,we identified the protein targets of andrographolide,a natural product with known anti-inflammation and anti-cancer effects,in live cancer cells.The identified target list not only confirmed the known functions of the drug but also revealed its potential novel application as a tumor metastasis inhibitor.We have also used this strategy,combining with a cleavable probe to identify the protein targets of aspirin and its binding sites.Our results revealed the roles of aspirin ininhibition of protein synthesis and induction of autophagy,which have been functionally validated.Our strategy is widely applicable to the identification of protein targets of covalent drugs. 展开更多
关键词 PROTEOMICS activity-based PROTEIN PROFILING androg
下载PDF
雄激素受体mRNA表达水平与T1期膀胱癌患者长期肿瘤特异性和无复发生存率的相关性研究 被引量:4
5
作者 杜乔 张辉 +1 位作者 卞少华 李颖毅 《国际外科学杂志》 2018年第1期15-19,后插3,封3,共7页
目的 探讨雄激素受体mRNA对T1期高危非肌层浸润性膀胱癌患者的临床预测价值.方法 回顾性分析2003年2月-2012年6月宝鸡市人民医院收治的196例经尿道膀胱肿瘤切除术治疗的T1期高危非肌层浸润性膀胱癌患者的病例资料.采用实时荧光定量PCR... 目的 探讨雄激素受体mRNA对T1期高危非肌层浸润性膀胱癌患者的临床预测价值.方法 回顾性分析2003年2月-2012年6月宝鸡市人民医院收治的196例经尿道膀胱肿瘤切除术治疗的T1期高危非肌层浸润性膀胱癌患者的病例资料.采用实时荧光定量PCR技术检测肿瘤标本中雄激素受体转录异构体1与转录异构体2的mRNA水平.采用Wilcoxon/Kruskal-Wallis检验和非参数Spearman秩相关系数rs对雄激素受体mRNA水平与角蛋白5和角蛋白20 mRNA的相关性进行分析.结果 Kaplan-Meier分析结果显示,雄激素受体转录异构体1 mRNA高表达(≥35.47)患者的无复发生存率、无进展生存率和肿瘤特异生存率均显著优于雄激素受体转录异构体1 mRNA低表达患者(P<0.05).多因素COX回归分析显示,雄激素受体转录异构体1 mRNA高表达是无复发生存率和肿瘤特异生存率的独立预测指标(P<0.05).非参数Spearman等级相关分析显示,雄激素受体转录异构体1 mRNA与角蛋白5 mRNA水平呈显著正相关(rs=0.3171,P<0.001),与多灶性肿瘤呈显著负相关(rs=0.1478,P<0.05).结论 雄激素受体mRNA的表达水平可以预测T1期高危非肌层浸润性膀胱癌患者的无复发生存率和肿瘤特异生存率.进一步研究雄激素受体mRNA水平的变化变得尤为重要. 展开更多
关键词 受体 雄激素 膀胱肿瘤 RNA 信使 生存率
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部